Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease
This concept article aims to show the rationale of targeting extracellular α-Synuclein (α-Syn) from cerebrospinal fluid (CSF) as a new strategy to remove this protein from the brain in Parkinson’s disease (PD). Misfolding and intracellular aggregation of α-synuclein into Lewy bodies are thought to b...
Main Authors: | Manuel Menéndez-González, Huber S. Padilla-Zambrano, Cristina Tomás-Zapico, Benjamin Fernández García |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-03-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3425/8/4/52 |
Similar Items
-
Quantification of alpha-synuclein in cerebrospinal fluid
by: Kronander, Björn
Published: (2012) -
Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
by: Mahsa Dolatshahi, et al.
Published: (2018-07-01) -
Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
by: Manuel Menendez-Gonzalez, et al.
Published: (2018-04-01) -
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
by: Maria Angela Samis Zella, et al.
Published: (2019-01-01) -
Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
by: Ning Shen, et al.
Published: (2019-05-01)